RxDoctor Payments Data

Michael Obrien, MD

Sports Medicine · New Orleans, LANPI 1104960657

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 74.8% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $95,027, 2.1 times the $44,403 reported in 2019. Among sports medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$390,783in general payments, 2019–2025

Across 300 payments — averaging $1302.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$292K
  • Exactech, Inc.$85K
  • Stryker$10K
  • ALON Medical Technology$1K
  • Shoulder Innovations, Inc.$425
  • Xiros Inc$398
  • plus $1K from 16 others
$6,136in research payments, 2019–2025

Across 2 payments — averaging $3067.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$6K

What the payments were for

  • Consulting fees$197,58051%
  • Speaking & faculty fees$153,27539%
  • Travel & lodging$24,4826%
  • Food & beverage$14,2384%
  • Education$1,2080%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$390,783 in reported general payments places this provider in the 95th percentile of 82 sports medicine providers in Louisiana.

See all sports medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$83,072
Medicare patients
140
Services billed
784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate11$693
Oxycodone Hcl104$568
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen52$482
Tramadol Hcl85$302
Ibuprofen18$260
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen27$228
Gabapentin36$209
Celecoxib19$207
Meloxicam54$144
Naproxen13$128
Methylprednisolone17$106
Prednisone25$51
Diazepam17$48
Cyclobenzaprine Hcl12$40
Amoxicillin15$11

Paid to pharmacies, not to this prescriber.

Other sports medicine in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →